AN OPEN LABEL, MULTICENTER, DOSE ESCALTION PHASE 1 STUDY TO EVALUATE SAFETY/TOLERANBILITY PHARMACOKINETICS PHARMACODYNAMICS AND PRELIMINARY ANTI TUMOR ACTIVITY OF RO7247669 A PD1-LAG3 BISPECIFIC ANTIBODY IN PATIENTS WITH ADVANCED AND /OR METASTATIC SOLID TUMORS
2019-000779-18TUMORES SÓLIDOS AVANZADOS Y / O METASTÁTICOSFundación Jiménez DíazInvestigador: MORENO GARCIA VICTOR
